Humanized monoclonal antibody specific for syndecan-1

Antitumor drug

The invention relates to immunology, biotechnology and medicine, namely, to the field of antitumor drugs based on monoclonal antibodies, and can be used for the treatment of oncological diseases. The proposed humanized monoclonal antibody (MAb), specific for syndecan-1 (CD138), belongs to the isotype of IgG4 kappa. The antibody is produced in mammalian cells using recombinant DNA technology and chromatographic purification techniques.

The invention received a prize at the international exhibition of inventions and innovative technologies «Archimedes»

Fill in your application

Please, fill in your application
Do you want to get a specialist consultation?